1674-0440
2012 Issue 6
Histamine H3 recetpor antagonists:research advances
WANG Huan;ZHENG Zhi-bing;LI Song
WANG Huan;ZHENG Zhi-bing;LI Song
..............page:455-459,463
Molecular targeted drugs on anti-angiogenesis in hepatocellular carcinoma:research advances
WANG Ming-qun 1;WANG Chang-zhen 2;WU Ke 2;LIU Ming-hua 1
WANG Ming-qun 1;WANG Chang-zhen 2;WU Ke 2;LIU Ming-hua 1
..............page:469-473
Cytotoxic effect of a novel therapeutic vaccine on cervical cancer
ZHANG Zhuo-mei 1;SONG Hai-jing 2;LI Na 3;ZOU Jia 3;JI Ying 4;WANG Qing-qing 3; CHEN Fang 3;GAO Xin 3;DONG Li-hou 3
ZHANG Zhuo-mei 1;SONG Hai-jing 2;LI Na 3;ZOU Jia 3;JI Ying 4;WANG Qing-qing 3; CHEN Fang 3;GAO Xin 3;DONG Li-hou 3
..............page:503-506
Research advances of myricetin
LIN Guo-bei 1;XIE Yan 1;LI Guo-wen 2
LIN Guo-bei 1;XIE Yan 1;LI Guo-wen 2
..............page:483-487
Transient receptor potential channel 6 as disease treatment target:research advances
LIU Ruo-fei;ZHANG Cui
LIU Ruo-fei;ZHANG Cui
..............page:474-477
..............page:441-444
Vascular disrupting agents targeting at tubulin:a novel class of antitumor drugs
WANG Xiao-feng;XIE Lan
WANG Xiao-feng;XIE Lan
..............page:445-454
N-type voltage-dependent calcium channel blockers on analgesia:research advances
PANG Chong 1;2;WU Ning 1;LI Jin 1
PANG Chong 1;2;WU Ning 1;LI Jin 1
..............page:464-468,473
Cassette dosing strategies based on LC-MS/MS for pharmacokinetic evaluation in early drug discovery:study and application
XU Li-kun;SONG Ya-bing;WANG Hong-quan
XU Li-kun;SONG Ya-bing;WANG Hong-quan
..............page:488-492
Gene polymorphism of CYP2C9 and clinical individualized drug therapy
CHEN Ling 1;WANG Jian 2;LI Ju-yi 1;ZOU Ji-li 1;WU Jin-hu 1
CHEN Ling 1;WANG Jian 2;LI Ju-yi 1;ZOU Ji-li 1;WU Jin-hu 1
..............page:493-497
Pulmonary administration of ciprofloxacin liposome:in vitro and in vivo evaluation
LIU Chun-mei 1;ZHANG Xiao-yang 2;BI Yun-qi 2;SUN Jian-xu 2;WANG Zhi-min 1;ZHENG Ai-ping 2
LIU Chun-mei 1;ZHANG Xiao-yang 2;BI Yun-qi 2;SUN Jian-xu 2;WANG Zhi-min 1;ZHENG Ai-ping 2
..............page:512-520
Lipoxygenase metabolism and lung cancer:research advances
YANG Yu-hua 1;2;WEI Xiao-li 1;ZHENG Jian-quan 1
YANG Yu-hua 1;2;WEI Xiao-li 1;ZHENG Jian-quan 1
..............page:478-482
Construction and identification of engineering cells CHO-hGPR91
CHEN Xi 1;2;HAN Chun-guang 2;HU Ming 3;LIU Chao 2;LIU Yong-xue 2
CHEN Xi 1;2;HAN Chun-guang 2;HU Ming 3;LIU Chao 2;LIU Yong-xue 2
..............page:507-511
..............page:525-528
guan zhu yao wu an quan xing
huang shi jie
huang shi jie
..............page:444,487
..............page:521-524,528,482,502,511
Down-regulation of GTPase activating protein(Src homology domain 3) binding protein 1 inhibits in vitro migration of human lung cancer cell A549
HAN Kun 1;2;ZHANG Ning 1;GENG Hua 1;CHEN Guo-jiang 2;LI Yan 2
HAN Kun 1;2;ZHANG Ning 1;GENG Hua 1;CHEN Guo-jiang 2;LI Yan 2
..............page:498-502
Chemical design of brain-targeting drug
QI Qian-qian 1;2;HE Yi-chao 1;2;XIAO Dian 1;ZHOU Xin-bo 1;ZHAO Guo-ming 1
QI Qian-qian 1;2;HE Yi-chao 1;2;XIAO Dian 1;ZHOU Xin-bo 1;ZHAO Guo-ming 1
..............page:460-463